Vanda Pharmaceuticals Inc (VNDA) — Financial Flexibility Index
Vanda Pharmaceuticals Inc (VNDA) has a Financial Flexibility Index of -0.18x as of December 2025. Free cash flow of $-29.32 Million (operating CF $-29.42 Million minus capex $102.00K) represents 0% of total liabilities ($161.76 Million). Check VNDA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vanda Pharmaceuticals Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Vanda Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see Vanda Pharmaceuticals Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Vanda Pharmaceuticals Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Vanda Pharmaceuticals Inc. Explore VNDA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.67x | $-108.44 Million | $-109.44 Million | $161.76 Million | ▼ -416.7% |
| 2024 | -0.13x | $-15.27 Million | $-15.76 Million | $117.66 Million | ▼ -201.9% |
| 2023 | 0.13x | $13.18 Million | $12.80 Million | $103.53 Million | ▼ -58.3% |
| 2022 | 0.31x | $32.66 Million | $31.98 Million | $107.05 Million | ▼ -58.1% |
| 2021 | 0.73x | $64.77 Million | $64.21 Million | $88.86 Million | ▲ +9.1% |
| 2020 | 0.67x | $53.57 Million | $51.77 Million | $80.19 Million | ▲ +3.6% |
| 2019 | 0.65x | $46.97 Million | $45.95 Million | $72.80 Million | ▼ -33.9% |
| 2018 | 0.98x | $55.35 Million | $29.99 Million | $56.71 Million | ▲ +22755.2% |
| 2017 | 0.00x | $-319.00K | $-1.98 Million | $74.04 Million | ▲ +94.9% |
| 2016 | -0.08x | $-6.70 Million | $-8.10 Million | $79.04 Million | ▼ -145.3% |
| 2015 | 0.19x | $14.98 Million | $12.45 Million | $80.02 Million | ▲ +102.8% |
| 2014 | -6.69x | $-72.78 Million | $-81.55 Million | $10.89 Million | ▼ -1583.0% |
| 2013 | -0.40x | $-39.42 Million | $-39.59 Million | $99.22 Million | ▼ -16.2% |
| 2012 | -0.34x | $-42.90 Million | $-44.92 Million | $125.54 Million | ▼ -81.1% |
| 2011 | -0.19x | $-28.14 Million | $-28.41 Million | $149.14 Million | ▼ -203.6% |
| 2010 | -0.06x | $-10.90 Million | $-10.90 Million | $175.37 Million | ▼ -106.9% |
| 2009 | 0.89x | $181.34 Million | $169.34 Million | $202.68 Million | ▲ +107.8% |
| 2008 | -11.50x | $-45.01 Million | $-45.96 Million | $3.91 Million | ▼ -194.1% |
| 2007 | -3.91x | $-51.36 Million | $-51.64 Million | $13.13 Million | ▲ +26.1% |
| 2006 | -5.29x | $-50.27 Million | $-51.62 Million | $9.50 Million | ▼ -54.5% |
| 2005 | -3.42x | $-17.42 Million | $-17.71 Million | $5.09 Million | ▲ +24.5% |
| 2004 | -4.53x | $-8.20 Million | $-8.61 Million | $1.81 Million | — |